Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

Alcon will have secured debt financing of $3.5 billion, adding that Bank of America Merrill Lynch and UBS were advising Novartis on the transaction. Novartis confirms Alcon eye care unit spin off ...

Alcon, Inc. engages in the development ... including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7 ®, the only one-week ...